Aller au contenu principal
Profil bibliographique

Marcus Järås

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

100Publications signalées
3279Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Acute Myeloid Leukemia ResearchSarcoma Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsImmune Cell Function and InteractionMedical Imaging and Pathology Studies

Les publications récentes

Accès ouvert 2025 preprint OpenAlex

The 3D genome of pediatric B-cell precursor acute lymphoblastic leukemia

Larissa Helena Moura‐Castro, Efe Aydın, Gladys Telliam Dushime, Eleanor L. Woodward et autres

Abstract Whereas the molecular pathogenesis of childhood B-cell precursor acute lymphoblastic leukemia (BCP ALL) has been studied extensively, its 3D chromatin landscape – of vast importance for gene regulation – remains poorly explored. Here, we applied Micro-C, a high-resolution variant of Hi-C, …

se (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 article OpenAlex

Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment

Nils Hansen, Pablo Peña‐Martínez, Petter Skoog, Katrin Reinbach et autres

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) represents a major clinical challenge due to its tumor microenvironment, which exhibits immune-suppressive properties that facilitate cancer progression, metastasis, and therapy resistance. Interleukin 1 (IL-1) signaling has been implicated as a driver in this process. Mechanistically, both …

se, us (code pays fourni par la source)

25 citations Journal for ImmunoTherapy of Cancer
Accès ouvert 2024 conference-abstract OpenAlex

Targeting Cholesterol Homeostasis Enhances Phagocytosis of Acute Myeloid Leukemia Cells

Somadri Ghosh, Katrin Reinbach, Pablo Peña‐Martínez, Ramprasad Ramakrishnan et autres

Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and is associated with poor outcome. While allogeneic stem cell transplantation can be curative, it is often accompanied by severe side-effects. Recently, there has been emerging recognition that …

se (code pays fourni par la source)

0 citations Blood
2024 conference-abstract OpenAlex

Abstract 2895: ILRAP blockade mediates anti-fibrotic effects in pancreatic cancer-associated fibroblasts

Neel Ingemann Nissen, Nils Hansen, Elin Jaensson Gyllenbäck, Camilla Rydberg Millrud et autres

Abstract Introduction: Pancreatic cancer (PDAC) patients have poor prognosis partly due to excessive activity of cancer-associated fibroblasts (CAFs). CAFs drive the fibrosis that causes excessive type III collagen and extracellular matrix deposition that in turn reduces drug response resulting in poor survival. …

dk, se (code pays fourni par la source)

1 citation Cancer Research
2023 conference-abstract OpenAlex

The 3D Chromatin Landscape of B-Cell Precursor Childhood Acute Lymphoblastic Leukemia

Larissa Helena Moura‐Castro, Minjun Yang, Eleanor L. Woodward, Anders Castor et autres

Whilst the molecular pathogenesis of childhood B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) has been studied extensively, its 3D chromatin landscape remains poorly explored. Genome-wide chromosome conformation capture methods have provided the tools to investigate the different units of chromatin organization, such …

se (code pays fourni par la source)

0 citations Blood
Accès ouvert 2023 conference-abstract OpenAlex

Targeting SLC3A2 Sensitizes AML Cells Towards NK Cell-Mediated Killing

Kishan Bellamkonda, Ramprasad Ramakrishnan, Somadri Ghosh, Katrin Reinbach et autres

Acute myeloid leukemia (AML) is an aggressive hematological malignancy with poor prognosis; hence, new therapeutic strategies are urgently needed. Natural Killer (NK) cells play a key role in tumor immune surveillance, but their anti-tumor activity in AML is often attenuated due to …

se (code pays fourni par la source)

0 citations Blood
2023 conference-abstract OpenAlex

H2-K1 on MLL-AF9 Leukemia Cells Facilitates the Escape of NK Cell-Mediated Immune Surveillance

Somadri Ghosh, Maria Rodriguez Zabala, Gladys Telliam Dushime, Katrin Reinbach et autres

Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults, and prognosis is poor; 5-year survival approximately 30%. Recently, there is an emerging recognition of the innate immune system, in particular Natural killer (NK) cells and macrophages, for …

se (code pays fourni par la source)

1 citation Blood
Accès ouvert 2023 article OpenAlex

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity

Maria Rodriguez‐Zabala, Ramprasad Ramakrishnan, Katrin Reinbach, Somadri Ghosh et autres

Acute myeloid leukemia (AML) is initiated and propagated by leukemia stem cells (LSCs), a self-renewing population of leukemia cells responsible for therapy resistance. Hence, there is an urgent need to identify new therapeutic opportunities targeting LSCs. Here, we performed an in vivo …

se (code pays fourni par la source)

29 citations Blood Advances
Accès ouvert 2023 article OpenAlex

Skin mesenchymal niches maintain and protect AML-initiating stem cells

Lakshmi Sandhow, Huan Cai, Elory Leonard, Pingnan Xiao et autres

Leukemia cutis or leukemic cell infiltration in skin is one of the common extramedullary manifestations of acute myeloid leukemia (AML) and signifies a poorer prognosis. However, its pathogenesis and maintenance remain understudied. Here, we report massive AML cell infiltration in the skin …

se (code pays fourni par la source)

7 citations The Journal of Experimental Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.